Literature DB >> 15141009

Multiparametric evaluation of apoptosis: effects of standard cytotoxic agents and the cyanoguanidine CHS 828.

Henrik Lövborg1, Peter Nygren, Rolf Larsson.   

Abstract

A multiparametric high-content screening assay for measurement of apoptosis was developed. HeLa cells and lymphoma U-937 cells were exposed to cytotoxic drugs in flat-bottomed optical microtiter plates. After incubation, the DNA-binding dye Hoechst 33342, fluorescein-tagged probes that covalently bind active caspases and chloromethyl-X-rosamine to detect mitochondrial membrane potential (MMP) were added. Image acquisition and quantitative measurement of fluorescence in a defined number of cells per well was performed using the automated image capture and analysis instrument ArrayScan. The usefulness of the assay was tested in cells exposed to standard cytotoxic drugs as well as in experimental cytotoxic cyanoguanidine CHS 828. A time- and dose-dependent activation of caspase-3, decrease in MMP, and increase in nuclear fragmentation and condensation were observed for the standard drugs, with the ability to correlate the parameters on a single cell basis. CHS 828 induced caspase-3 activation and reduction in MMP with modest changes in nuclear morphology. The method described was considered to be a rapid and information-rich apoptosis assay suitable both for correlating morphological and biochemical apoptotic events in single cells as well as for screening and evaluation of novel substances with apoptosis-inducing capabilities.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15141009

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN: 1535-7163            Impact factor:   6.261


  15 in total

1.  Applying Small Molecule Signal Transducer and Activator of Transcription-3 (STAT3) Protein Inhibitors as Pancreatic Cancer Therapeutics.

Authors:  Carolyn C Arpin; Stephen Mac; Yanlin Jiang; Huiwen Cheng; Michelle Grimard; Brent D G Page; Malgorzata M Kamocka; Sina Haftchenary; Han Su; Daniel P Ball; David A Rosa; Ping-Shan Lai; Rodolfo F Gómez-Biagi; Ahmed M Ali; Rahul Rana; Helmut Hanenberg; Kagan Kerman; Kyle C McElyea; George E Sandusky; Patrick T Gunning; Melissa L Fishel
Journal:  Mol Cancer Ther       Date:  2016-02-12       Impact factor: 6.261

2.  Asterosaponin 1, a cytostatic compound from the starfish Culcita novaeguineae, functions by inducing apoptosis in human glioblastoma U87MG cells.

Authors:  Guang Cheng; Xiang Zhang; Hai-Feng Tang; Yun Zhang; Xin-Hai Zhang; Wei-Dong Cao; Da-Kuan Gao; Xi-Ling Wang; Bo-quan Jin
Journal:  J Neurooncol       Date:  2006-04-21       Impact factor: 4.130

3.  Immunological synapse formation inhibits, via NF-kappaB and FOXO1, the apoptosis of dendritic cells.

Authors:  Lorena Riol-Blanco; Cristina Delgado-Martín; Noelia Sánchez-Sánchez; Luis M Alonso-C; María Dolores Gutiérrez-López; Gloria Martínez Del Hoyo; Joaquín Navarro; Francisco Sánchez-Madrid; Carlos Cabañas; Paloma Sánchez-Mateos; José Luis Rodríguez-Fernández
Journal:  Nat Immunol       Date:  2009-06-07       Impact factor: 25.606

4.  Nanoparticulate Quillaja saponin induces apoptosis in human leukemia cell lines with a high therapeutic index.

Authors:  Kefei Hu; Saideh Berenjian; Rolf Larsson; Joachim Gullbo; Peter Nygren; Tanja Lövgren; Bror Morein
Journal:  Int J Nanomedicine       Date:  2010-02-02

Review 5.  Miniaturized pre-clinical cancer models as research and diagnostic tools.

Authors:  Maria Håkanson; Edna Cukierman; Mirren Charnley
Journal:  Adv Drug Deliv Rev       Date:  2013-12-01       Impact factor: 15.470

6.  The small molecule GMX1778 is a potent inhibitor of NAD+ biosynthesis: strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumors.

Authors:  Mark Watson; Anne Roulston; Laurent Bélec; Xavier Billot; Richard Marcellus; Dominique Bédard; Cynthia Bernier; Stéphane Branchaud; Helen Chan; Kenza Dairi; Karine Gilbert; Daniel Goulet; Michel-Olivier Gratton; Henady Isakau; Anne Jang; Abdelkrim Khadir; Elizabeth Koch; Manon Lavoie; Michael Lawless; Mai Nguyen; Denis Paquette; Emilie Turcotte; Alvin Berger; Matthew Mitchell; Gordon C Shore; Pierre Beauparlant
Journal:  Mol Cell Biol       Date:  2009-08-24       Impact factor: 4.272

7.  The chemopotential effect of Annona muricata leaves against azoxymethane-induced colonic aberrant crypt foci in rats and the apoptotic effect of Acetogenin Annomuricin E in HT-29 cells: a bioassay-guided approach.

Authors:  Soheil Zorofchian Moghadamtousi; Elham Rouhollahi; Hamed Karimian; Mehran Fadaeinasab; Mohammad Firoozinia; Mahmood Ameen Abdulla; Habsah Abdul Kadir
Journal:  PLoS One       Date:  2015-04-10       Impact factor: 3.240

8.  Inhibitory effect of Curcuma purpurascens BI. rhizome on HT-29 colon cancer cells through mitochondrial-dependent apoptosis pathway.

Authors:  Elham Rouhollahi; Soheil Zorofchian Moghadamtousi; Mohammadjavad Paydar; Mehran Fadaeinasab; Maryam Zahedifard; Maryam Hajrezaie; Omer Abdalla Ahmed Hamdi; Chung Yeng Looi; Mahmood Ameen Abdulla; Khalijah Awang; Zahurin Mohamed
Journal:  BMC Complement Altern Med       Date:  2015-02-05       Impact factor: 3.659

9.  Identification of molecular mechanisms for cellular drug resistance by combining drug activity and gene expression profiles.

Authors:  L Rickardson; M Fryknäs; S Dhar; H Lövborg; J Gullbo; M Rydåker; P Nygren; M G Gustafsson; R Larsson; A Isaksson
Journal:  Br J Cancer       Date:  2005-08-22       Impact factor: 7.640

10.  Screening for phenotype selective activity in multidrug resistant cells identifies a novel tubulin active agent insensitive to common forms of cancer drug resistance.

Authors:  Mårten Fryknäs; Joachim Gullbo; Xin Wang; Linda Rickardson; Malin Jarvius; Malin Wickström; Saadia Hassan; Claes Andersson; Mats Gustafsson; Gunnar Westman; Peter Nygren; Stig Linder; Rolf Larsson
Journal:  BMC Cancer       Date:  2013-08-06       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.